Clinical Trials Logo

Filter by:
NCT ID: NCT00532181 Not yet recruiting - Clinical trials for Health Insurance Sale

Micro-Health Insurance in Cambodia

Start date: April 2008
Phase: Phase 0
Study type: Interventional

People who buy insurance are sicker and/or more risk averse than those who don't. Also, Micro-health insurance increases utilization of public health care facilities and protects against asset sales.

NCT ID: NCT00606164 Not yet recruiting - Alzheimer's Disease Clinical Trials

Safety, Efficacy, Pharmacokinetics, and Pharmacodynamics Study of Bryostatin 1 in Patients With Alzheimer's Disease

Start date: April 2008
Phase: Phase 2
Study type: Interventional

The main purpose of this study is find out how safe a single dose of bryostatin 1 is in patients with Alzheimer's Disease (AD). This study is also being done 1) to determine how effective a single dose of bryostatin 1 is in the treatment of AD, 2) to find out what happens to bryostatin 1 once it enters the body by measuring the levels of bryostatin 1 in blood, and 3) to measure a substance in the blood (protein kinase C) that may help to better understand how bryostatin 1 works.

NCT ID: NCT00619437 Not yet recruiting - Schizophrenia Clinical Trials

Genetics of Schizophrenia

Start date: April 2008
Phase: N/A
Study type: Observational

Genetic etiology in schizophrenia is widely accepted. However, many chromosomal sites were shown to characterize the families of patients with schizophrenia. This is probably due to the high genetic heterogenity of this illness. Thus, it is important to investigate the genetic factor in relatively genetically homogenous populations. Many studies have indicate that Ashkenazy Jews show relative gentic homogenity. Indeed, the genes responsible for most Mendelian disorders of Jewish peoples have been identified. The study will apply genome-wide mutation screening methods to identify candidate allells in subjects of Ashkenazi Jewish ancestry with multiplex schizophrenia.

NCT ID: NCT00627718 Not yet recruiting - Clinical trials for Age-Related Macular Degeneration

Assessment of Macular Edema Using HRT Technique

Start date: April 2008
Phase: N/A
Study type: Interventional

Age Related Macular Degeneration (ARMD) is the most common cause of irreversible blindness in people of age 50 or older in the western populations. ARMD has two forms, the wet and the dry forms. The wet form is more serious and can lead to irreversible loss of vision. In the wet form of ARMD, new blood vessels grow under the retina. These blood vessels leak blood and fluid and cause the retina and the macula to swell. So the thickness of the macula increases. One of the key factors in the treatment of wet ARMD is early diagnosis and treatment to prevent complete visual loss. In this research, we are going to use a technique, called the Heidelberg retinal tomograph (HRT) to measure and compare the thickness of the macula in healthy controls and in patients suspected of having ARMD. HRT is a non-invasive imaging system that uses laser to measure the thickness of the macula. This allows us to come up with a quite simple and easy-to-use technique that helps us to diagnose wet ARMD early and treat it before visual acuity is completely lost.

NCT ID: NCT00631982 Not yet recruiting - Infertility Clinical Trials

Invitro Maturation of Oocytes for Patients With Polycystic Ovaries

Start date: April 2008
Phase: N/A
Study type: Interventional

In vitro maturation of oocytes after minimal gonadotropin stimulation in patients with polycystic ovaries, to prevent cases of ovarian hyperstimulation.

NCT ID: NCT00637065 Not yet recruiting - Clinical trials for Pulmonary Hypertension

Bosentan in Pulmonary Hypertension in Interstitial Lung Disease Treatment Study

B-PHIT
Start date: April 2008
Phase: Phase 4
Study type: Interventional

Over time, patients with fibrosing or interstitial lung disease (ILD) can develop high lung blood pressures (pulmonary hypertension), and this is associated with poorer prognosis and survival. It is thought that development of PH contributes to the deterioration and death of patients with ILD. Endothelin-1 (ET1) is a substance contributing to the development of both PH and ILD. Bosentan is a drug blocking the action of ET-1 by binding to its receptors. Bosentan clearly benefits patients with PH of unknown cause, or related to other diseases (such as heart conditions, or HIV) both alone and in combination with other treatments. In patients with fibrosing lung disease and PH, there have been no controlled treatment studies. Clearly it is important to evaluate the effectiveness of bosentan in these patients. This study aims to determine the ability of bosentan to reduce high blood pressure in the lungs (pulmonary hypertension) in patients with scarring (fibrosing) lung disease. It is a placebo-controlled double blinded study for 16 weeks (and it is proposed to follow patients in a 16 week open-label phase with bosentan therapy).

NCT ID: NCT00638586 Not yet recruiting - Clinical trials for Radial Artery Access

Comparison of Patients Undergoing Radial or Femoral Arterial Access for Percutaneous Catheterization-Nursing Aspects

Start date: April 2008
Phase: N/A
Study type: Observational

Transradial access is a recently developed alternative for diagnostic andf interventional cardiac catheterization. We sought to compare the differences between patients that have undergone PTCA transradial and transfemoral access from the nursing point of view: 1. Anxiety levels 2. Pain at access point, pain in general and level of pain during mobility 3. Differences in feelings of embarrassement 4. Differences in satisfaction

NCT ID: NCT00641290 Not yet recruiting - Clinical trials for Ischemic Heart Disease

Vigileo FloTrac vs Pulmonary Artery Catheter

Start date: April 2008
Phase: N/A
Study type: Observational

To study the role of Vigileo monitor using the FloTrac sensor to measure cardiac output using the pulse contour analysis as well as central venous oxygen saturation monitoring as a guide for tissue perfusion. The accuracy of the Vigileo monitoring was compared with the conventional thermodilution method for measuring cardiac output using the pulmonary artery catheter and mixed venous oxygen saturation for assessing global tissue perfusion.

NCT ID: NCT00641355 Not yet recruiting - Sepsis Clinical Trials

Acute Phase Proteins as Early Markers in Sepsis

Start date: April 2008
Phase: N/A
Study type: Observational

Monitoring of different serumproteins after severe trauma and during trauma-induced sepsis. - Trial with surgical intervention

NCT ID: NCT00650897 Not yet recruiting - Diabetes Mellitus Clinical Trials

Efficacy Study of Escitalopram for Depression in Patients With Diabetes

EFDID
Start date: April 2008
Phase: Phase 4
Study type: Interventional

Patients with diabetes and major depression treated with Escitalopram might experience significant improvement in depression and anxiety scores; functional ability; diabetes-related self-care; and pain symptoms